Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222703 · ClinicalTrials.gov registry record · NA
Enhancing Tobacco Abstinence Following Hospitalization
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00222703 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 80 participants.
The verdict
NCT00222703, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The primary aim of this study is to examine the efficacy of a 12-week nurse-delivered relapse management intervention designed with conceptual underpinnings from Self-efficacy Theory to enhance smoking abstinence of hospitalized smokers following their hospital discharge. Specifically this study asks, does a 12-week Self-efficacy Theory driven relapse management intervention enhance smoking abstinence following hospitalization by increasing smoking abstinence point prevalence as measured by carbon monoxide validated self-reports of smoking, when compared to subjects receiving only enhanced usual care?
Interventions
- BEHAVIORAL Smoking relapse prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2002-05 |
| Est. Completion | 2005-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222703
The ClinicalTrials.gov registry entry for NCT00222703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking relapse prevention is the first listed.
NCT00222703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222703 about?
NCT00222703 is a clinical study titled "Enhancing Tobacco Abstinence Following Hospitalization". The primary aim of this study is to examine the efficacy of a 12-week nurse-delivered relapse management intervention designed with conceptual underpinnings from Self-efficacy Theory to enhance smoking abstinence of hospitalized smokers following their hospital discharge. Specifically this study ask...
What is the current status of trial NCT00222703?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2002-05. Estimated completion is 2005-03.
What interventions are being tested in trial NCT00222703?
The interventions under investigation include: Smoking relapse prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00222703?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.